Atlas Trials

A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)

Clinical trial NCT03821610 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03821610
Sponsor
University of Birmingham
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia
Start date
2018-11-22
Primary completion
2025-10-31
Enrollment
242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.